Indefinite Delivery Contract SPE2DX16D9958

This Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various categories such as injections, tablets, creams, auto-injectors, and specialty medications.

This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites worldwide. The contract covers an extensive portfolio of medical products, from contraceptive devices to oncology treatments, auto-injectors, and specialized pharmaceutical items, supporting the medical supply needs of military health facilities. This single-award IDC leverages DMS Pharmaceutical Group's status as a woman-owned small business to effectively compete in federal procurement markets without any set-aside designations.